Most Read News

The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and 7.5 mg dosages.

EBITDA increased by 3% to ₹47.8 Crore in the second quarter of this fiscal year, up from ₹46.4 Crore in the same period last year.

The project is expected to take three years to complete, and the corporation will earn a 10-year maintenance contract for it.

The cosmetics company reported a profit of ₹5.85 Crore in the same quarter previous year. On a quarterly basis, net profit increased 4.1%.

On the last day of bidding, which was dominated by retail buyers, Sagility India's IPO was subscribed for 3.2 times.

The record SIP flows of ₹25,323 Crore in October 2024 highlights a new peak in the SIP journey

The 35.6% yoy growth in mutual fund folios in October 2024 shows that mutual funds are a truly retail franchise

Mutual fund AUM at ͅ₹67.26 Trillion was flat despite the sharp inflows in October as the market sell-off offset the inflows

Notably, more than 25% of these orders came from the EV segment, demonstrating the company's commitment to EV market growth.

The company observed reduced staff expenses and regulatory contributions, as well as a significant 14% quarter-on-quarter (QoQ) decrease.